These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 20939755)
1. In vivo efficacy of sivelestat in combination with pazufloxacin against Legionella pneumonia. Morinaga Y; Yanagihara K; Araki N; Yamada K; Seki M; Izumikawa K; Kakeya H; Yamamoto Y; Yamada Y; Kohno S; Kamihira S Exp Lung Res; 2010 Oct; 36(8):484-90. PubMed ID: 20939755 [TBL] [Abstract][Full Text] [Related]
2. Effects of specific neutrophil elastase inhibitor, sivelestat sodium hydrate, in murine model of severe pneumococcal pneumonia. Yanagihara K; Fukuda Y; Seki M; Izumikawa K; Miyazaki Y; Hirakata Y; Tsukamoto K; Yamada Y; Kamhira S; Kohno S Exp Lung Res; 2007 Mar; 33(2):71-80. PubMed ID: 17454103 [TBL] [Abstract][Full Text] [Related]
3. Effects of elastase inhibitor on the epithelial cell apoptosis in bleomycin-induced pulmonary fibrosis. Song JS; Kang CM; Rhee CK; Yoon HK; Kim YK; Moon HS; Park SH Exp Lung Res; 2009 Dec; 35(10):817-29. PubMed ID: 19995276 [TBL] [Abstract][Full Text] [Related]
5. Sequential changes of Legionella antigens and bacterial load in the lungs and urines of a mouse model of pneumonia. Chen Y; Tateda K; Fujita K; Ishii T; Ishii Y; Kimura S; Saga T; Annaka T; Yamada S; Zhao L; Li S; Azuma A; Gemma A; Kudoh S; Yamaguchi K Diagn Microbiol Infect Dis; 2010 Mar; 66(3):253-60. PubMed ID: 20159373 [TBL] [Abstract][Full Text] [Related]
6. Severe Legionnaires' disease successfully treated using a combination of fluoroquinolone, erythromycin, corticosteroid, and sivelestat. Kakeya H; Ehara N; Fukushima K; Seki M; Izumikawa K; Yamamoto Y; Yanagihara K; Saito A; Kohno S Intern Med; 2008; 47(8):773-7. PubMed ID: 18421197 [TBL] [Abstract][Full Text] [Related]
7. Administration of a specific inhibitor of neutrophil elastase attenuates pulmonary fibrosis after acute lung injury in mice. Fujino N; Kubo H; Suzuki T; He M; Suzuki T; Yamada M; Takahashi T; Ota C; Yamaya M Exp Lung Res; 2012 Feb; 38(1):28-36. PubMed ID: 22148910 [TBL] [Abstract][Full Text] [Related]
8. The effect of sivelestat sodium on post-cardiopulmonary bypass acute lung injury in a neonatal piglet model. Ando M; Murai T; Takahashi Y Interact Cardiovasc Thorac Surg; 2008 Oct; 7(5):785-8. PubMed ID: 18596053 [TBL] [Abstract][Full Text] [Related]
10. [Pneumonia due to Legionella pneumophila in an immunocompromised child]. van Dijk K; Kamphuis S; Geelen SP; Wulffraat NM; van Gestel JP; Wolfs TF Ned Tijdschr Geneeskd; 2002 Jul; 146(30):1420-3. PubMed ID: 12174438 [TBL] [Abstract][Full Text] [Related]
11. Role of rifampin-based combination therapy for severe community-acquired Legionella pneumophila pneumonia. Varner TR; Bookstaver PB; Rudisill CN; Albrecht H Ann Pharmacother; 2011 Jul; 45(7-8):967-76. PubMed ID: 21775694 [TBL] [Abstract][Full Text] [Related]
12. In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia. Edelstein PH; Shinzato T; Doyle E; Edelstein MA Antimicrob Agents Chemother; 2001 Aug; 45(8):2204-9. PubMed ID: 11451675 [TBL] [Abstract][Full Text] [Related]
13. Elastase inhibition reduced death associated with acid aspiration-induced lung injury in hamsters. Hagio T; Matsumoto S; Nakao S; Abiru T; Ohno H; Kawabata K Eur J Pharmacol; 2004 Mar; 488(1-3):173-80. PubMed ID: 15044049 [TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 4 is not involved in host defense against pulmonary Legionella pneumophila infection in a mouse model. Lettinga KD; Florquin S; Speelman P; van Ketel R; van der Poll T; Verbon A J Infect Dis; 2002 Aug; 186(4):570-3. PubMed ID: 12195388 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of pazufloxacin mesilate in Legionnaires' disease: a case report and in vitro study of the isolate. Higa F; Shinzato T; Toyama M; Haranaga S; Furugen M; Tateyama M; Kawakami K; Saito A J Infect Chemother; 2005 Jun; 11(3):164-8. PubMed ID: 15990982 [TBL] [Abstract][Full Text] [Related]
16. Sivelestat reduces reperfusion injury of lungs harvested from endotoxin-primed rats by inhibition of neutrophil-mediated inflammation. Suzuki S; Sugawara T; Tabata T; Oishi H; Niikawa H; Kondo T J Heart Lung Transplant; 2007 Apr; 26(4):370-5. PubMed ID: 17403479 [TBL] [Abstract][Full Text] [Related]
17. The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila. Nakamura S; Yanagihara K; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Senjyu H; Saito A; Kohno S J Infect; 2009 Sep; 59(3):222-4. PubMed ID: 19592113 [No Abstract] [Full Text] [Related]
18. Delayed neutrophil elastase inhibition prevents subsequent progression of acute lung injury induced by endotoxin inhalation in hamsters. Kawabata K; Hagio T; Matsumoto S; Nakao S; Orita S; Aze Y; Ohno H Am J Respir Crit Care Med; 2000 Jun; 161(6):2013-8. PubMed ID: 10852782 [TBL] [Abstract][Full Text] [Related]
19. BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs. Edelstein PH; Shinzato T; Edelstein MA J Antimicrob Chemother; 2001 Nov; 48(5):667-75. PubMed ID: 11679556 [TBL] [Abstract][Full Text] [Related]
20. The mouse as a model for pulmonary legionella infection. Hori JI; Zamboni DS Methods Mol Biol; 2013; 954():493-503. PubMed ID: 23150416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]